Live price temporarily unavailable.
Tevogen Bio Holdings Inc (TVGN) is a Health Care company. Latest news and coverage below.
| FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|
| Income statement | ||||
| Operating income | — | −$8.84M | −$53.6M | −$26.1M |
| Net income | $4.41M | −$60.5M | −$13.7M | −$26.3M |
| EPS (diluted) | — | −$122.00 | −$3.50 | −$8.08 |
| Balance sheet | ||||
| Cash and equivalents | $129.2K | $0 | $0 | $0 |
| Total assets | $357.1M | $5.51M | $3.46M | $4.38M |
| Total liabilities | $15.1M | $99.9M | $10.1M | $12.6M |
| Shareholders' equity | −$34.0M | −$94.4M | −$6.67M | −$8.23M |
| Cash flow | ||||
| Operating cash flow | −$215.4K | −$8.17M | −$12.0M | −$12.3M |
| Capital expenditure | — | $133.0K | — | $64.4K |
| Free cash flow | — | −$8.30M | — | −$12.4M |
| Share buybacks | — | $343.0M | — | — |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | −$6.09M | −$9.36M | −$10.4M | −$5.44M | −$5.73M | −$4.61M | −$5.40M | −$5.66M |
| Net income | −$5.88M | −$9.44M | −$10.4M | −$5.50M | −$5.73M | −$4.68M | −$5.45M | −$5.76M |
| EPS (diluted) | −$1.50 | $13.00 | −$3.25 | −$1.71 | −$1.50 | −$1.62 | −$1.61 | −$1.52 |
| Balance sheet | ||||||||
| Cash and equivalents | $2.33M | $0 | $1.97M | $685.2K | $1.04M | $0 | $692.3K | $1.08M |
| Total assets | $4.29M | $3.46M | $4.07M | $4.27M | $4.49M | $4.38M | $4.92M | $4.73M |
| Total liabilities | $10.5M | $10.1M | $11.8M | $13.8M | $12.3M | $12.6M | $14.8M | $13.6M |
| Shareholders' equity | −$6.19M | −$6.67M | −$7.72M | −$9.48M | −$7.82M | −$8.23M | −$9.84M | −$8.89M |
| Cash flow | ||||||||
| Operating cash flow | −$3.80M | −$3.05M | −$3.31M | −$3.19M | −$3.65M | −$2.18M | −$2.73M | −$3.01M |
From Tevogen Bio Holdings Inc's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
No recent news mentioning Tevogen Bio Holdings Inc in our feed yet.